BENZODIAZEPIN-BROMODOMÄNENHEMMER

European patent · EP2496582 · Deleted

Register entry

Publication number
EP2496582
Application number
EP10773325
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 3, 2010
Published
Sep 12, 2012
Granted
Jan 27, 2016
Deleted
Jun 29, 2022
Reason
Annual fee unpaid
IPC classes
C07D 487/04 (2006.01)
A61K 31/55 (2006.01)
A61P 35/00 (2006.01)
A61P 43/00 (2006.01)
Priority
GB 0919433 05.11.2009
GB 201010509 22.06.2010
WO PCT/EP2010/061518 06.08.2010
GB 201014231 25.08.2010
PCT application
PCT/EP2010/066697 03.11.2010
PCT publication
WO2011/054845 12.05.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 29, 2022

    Deleted, fee unpaid

    Published in Swissreg on 29.06.2022

  2. Feb 24, 2016

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 24.02.2016

  3. Jan 27, 2016

    Granted

    Published in Swissreg on 27.01.2016

Parties

Holder

GlaxoSmithKline LLC

Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, Delaware 19808, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

BAILEY, James

Stevenage Hertfordshire SG1 2NY, GB

GOSMINI, Romain, Luc, Marie

F-91951 Les Ulis, FR

MIRGUET, Olivier

F-91951 Les Ulis, FR

WITHERINGTON, Jason

Stevenage Hertfordshire SG1 2NY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.